Viewing Study NCT01324128


Ignite Creation Date: 2025-12-26 @ 11:12 AM
Ignite Modification Date: 2026-01-13 @ 9:42 AM
Study NCT ID: NCT01324128
Status: COMPLETED
Last Update Posted: 2014-04-24
First Post: 2011-03-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
Sponsor: Vifor Pharma
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PA-CL-05A
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View